RPGLIFE — RPG Life Sciences Share Price
0.000.00%
Last trade - 00:00- IN₹29.68bn
- IN₹28.40bn
- IN₹5.82bn
- 91
- 13
- 87
- 73
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 6.87 | ||
| Price to Tang. Book | 7.43 | ||
| Price to Free Cashflow | 102.49 | ||
| Price to Sales | 4.42 | ||
| EV to EBITDA | 19.1 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 29.09% | ||
| Return on Equity | 25.69% | ||
| Operating Margin | 19.08% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 3,755.7 | 3,891.4 | 4,401.6 | 5,128.1 | 5,820.5 | n/a | n/a | 12.01% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +207.12 | +20.03 | +28.68 | +32.51 | +28.52 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
RPG Life Sciences Limited is an India-based pharmaceutical company. The Company operates in the domestic and international markets in the formulations, generics, and synthetic active pharmaceutical ingredients (APIs) space. Its business portfolio includes domestic formulations, international formulations and APIs. Its domestic formulation business manufactures and markets branded finished dosage formulations in India. The domestic formulations business has presence in over 10 therapeutic areas, including nephrology, oncology, rheumatology, cardiology, respiratory, nutritional, gastroenterology, and diabetology, among others. The international formulations business is involved in developing, manufacturing and marketing oral solid formulations in the generic and branded generic space across regulated and emerging markets. Its products include Azoran, Mofetyl, Arpimune ME, Azathioprine, Sodium Valproate PR, Nicorandil, Quinfamide, Nicorandil, Haloperidol, Risperidone, and others.
Directors
- Harsh Goenka NEC (61)
- Rajindrra Patkar CEX
- Vimalendu Singh CEX
- Uday Bapat CSO
- Rajesh Shirambekar CCO
- Mahesh Narayanaswamy VFN (52)
- Yugal Sikri MDR
- Suchitra Tiwari GMG
- Rajat Bhargava NED
- Sachin Nandgaonkar NED
- Narendra Ambwani IND
- Bhaskar Iyer IND
- Zahabiya Khorakiwala IND
- Mahesh Gupta NID (62)
- Lalit Kanodia NID
- Manoj Maheshwari NID (61)
- Last Annual
- March 31st, 2024
- Last Interim
- March 31st, 2024
- Incorporated
- March 29th, 2007
- Public Since
- June 10th, 2008
- No. of Employees
- 1,165
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 16,539,015
- Address
- RPG House, MUMBAI, 400030
- Web
- https://www.rpglifesciences.com/website/index.php
- Phone
- +91 2224981650
- Contact
- Rajesh Shirambekar
- Auditors
- SRBC & Co LLP
Upcoming Events for RPGLIFE
RPG Life Sciences Limited Annual Shareholders Meeting
Q1 2025 RPG Life Sciences Limited Earnings Release
RPG Life Sciences Limited Annual Shareholders Meeting
Q2 2025 RPG Life Sciences Limited Earnings Release
Similar to RPGLIFE
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
What is the RPG Life Sciences share price?
As of Today at 17:02 UTC, shares in RPG Life Sciences are trading at IN₹1,557.25. This share price information is delayed by 15 minutes.
How has the RPG Life Sciences share price performed this year?
Shares in RPG Life Sciences last closed at IN₹1,557.25 and the price had moved by +75.45% over the past 365 days. In terms of relative price strength the RPG Life Sciences share price has outperformed the S&P BSE 100 Index by +34.06% over the past year.
What are the analyst and broker recommendations for RPG Life Sciences?
The overall consensus recommendation for RPG Life Sciences is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the RPG Life Sciences dividend yield?
The RPG Life Sciences dividend yield is 1.03% based on the trailing twelve month period.
Does RPG Life Sciences pay a dividend?
Last year, RPG Life Sciences paid a total dividend of IN₹16.00, and it currently has a trailing dividend yield of 1.03%.Looking ahead, shares in RPG Life Sciences are due to go ex-dividend on 2024-06-28 and the next dividend pay date is 2024-08-15.
When does RPG Life Sciences next pay dividends?
RPG Life Sciences are due to go ex-dividend on 2024-06-28 and the next dividend pay date is 2024-08-15. The historic dividend yield on RPG Life Sciences shares is currently 1.03%.
How do I buy RPG Life Sciences shares?
To buy shares in RPG Life Sciences you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of RPG Life Sciences?
As of the previous close price of IN₹1,557.25, shares in RPG Life Sciences had a market capitalisation of IN₹25.76bn.
Where are RPG Life Sciences shares listed?
Here are the trading details for RPG Life Sciences:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: RPGLIFE
What kind of share is RPG Life Sciences?
Based on an overall assessment of its quality, value and momentum RPG Life Sciences is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a RPG Life Sciences share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the RPG Life Sciences share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like RPG Life Sciences. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +1.53%.
As of the last closing price of IN₹1,557.25, shares in RPG Life Sciences were trading +7.33% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the RPG Life Sciences PE Ratio?
The RPG Life Sciences PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹1,557.25.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of RPG Life Sciences?
RPG Life Sciences' management team is headed by:
- Harsh Goenka - NEC
- Rajindrra Patkar - CEX
- Vimalendu Singh - CEX
- Uday Bapat - CSO
- Rajesh Shirambekar - CCO
- Mahesh Narayanaswamy - VFN
- Yugal Sikri - MDR
- Suchitra Tiwari - GMG
- Rajat Bhargava - NED
- Sachin Nandgaonkar - NED
- Narendra Ambwani - IND
- Bhaskar Iyer - IND
- Zahabiya Khorakiwala - IND
- Mahesh Gupta - NID
- Lalit Kanodia - NID
- Manoj Maheshwari - NID